EFTR
Geode Capital Management’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-25,583
| Closed | -$7.42K | – | 4666 |
|
|
2024
Q2 | $7.42K | Buy |
25,583
+2,974
| +13% | +$863 | ﹤0.01% | 4557 |
|
|
2024
Q1 | $325K | Sell |
22,609
-385,365
| -94% | -$5.55M | ﹤0.01% | 3771 |
|
|
2023
Q4 | $191K | Buy |
407,974
+144,216
| +55% | +$67.4K | ﹤0.01% | 3959 |
|
|
2023
Q3 | $158K | Buy |
263,758
+158,776
| +151% | +$95.3K | ﹤0.01% | 4073 |
|
|
2023
Q2 | $87.2K | Hold |
104,982
| – | – | ﹤0.01% | 4378 |
|
|
2023
Q1 | $37.8K | Sell |
104,982
-1,364
| -1% | -$491 | ﹤0.01% | 4581 |
|
|
2022
Q4 | $45K | Hold |
106,346
| – | – | ﹤0.01% | 4624 |
|
|
2022
Q3 | $60K | Hold |
106,346
| – | – | ﹤0.01% | 4726 |
|
|
2022
Q2 | $151K | Hold |
106,346
| – | – | ﹤0.01% | 4414 |
|
|
2022
Q1 | $426K | Buy |
106,346
+10,545
| +11% | +$42.2K | ﹤0.01% | 4019 |
|
|
2021
Q4 | $793K | Buy |
95,801
+71,796
| +299% | +$594K | ﹤0.01% | 3821 |
|
|
2021
Q3 | $337K | Buy |
+24,005
| New | +$337K | ﹤0.01% | 4211 |
|